Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Risk-Stratified Screening: A Simulation Study of Scheduling Templates on Daily Mammography Recalls
6
Zitationen
7
Autoren
2025
Jahr
Abstract
INTRODUCTION: Risk-stratified screening (RSS) scheduling may facilitate more effective use of same-day diagnostic testing for potentially abnormal mammograms, thereby reducing the need for follow-up appointments ("recall"). Our simulation study assessed the potential impact of RSS scheduling on patients recommended for same-day diagnostics. METHODS: We used a discrete event simulation to model workflow at a high-volume breast imaging center, incorporating artificial intelligence (AI)-triaged same-day diagnostic workups after screening mammograms. The RSS design sequences patients in the daily screening schedule using cancer risk categories developed from Tyrer-Cuzick and deep learning model scores. We compared recall variance, required hours of operation to accommodate all patients, and patient wait times using traditional (random) and RSS schedules. RESULTS: The baseline simulation included 60 daily patients, with an average of 42% receiving screening mammograms and 11% (about three patients) being recommended for diagnostic workups. Compared with traditional scheduling, RSS scheduling reduces recall variance by up to 30% (1.98 versus 2.82, P < .05). With same-day diagnostics, RSS scheduling had a modest impact, increasing the number of patients served within normal operating hours by up to 1.3% (55.4 versus 54.7, P < .05), decreasing necessary operational hours by 12 min (10.3 versus 10.5 hours, P < .05), and increasing patient waiting times by an average of 2.4 min (0.24 versus 0.20 hours, P < .05). CONCLUSION: Our simulation study suggests that RSS scheduling could reduce recall variance. This approach might enable same-day diagnostics using AI triage by accommodating patients within normal operating hours.
Ähnliche Arbeiten
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · 111.597 Zit.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · 87.522 Zit.
Global cancer statistics
2011 · 55.024 Zit.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 · 29.001 Zit.
Global cancer statistics, 2012
2015 · 27.340 Zit.